Definition

Pulmonary rehabilitation is defined as an evidence-based, multidisciplinary, comprehensive intervention that can be integrated into the management of individuals with chronic lung disease. Pulmonary rehabilitation is a multifaceted program, which involves optimization of medical management, physical conditioning, education, nutritional counseling, coping skills, and psychosocial support with the goal of reducing symptoms, improving functional status, increasing exercise tolerance, psychological well-being, quality of life, and reducing health care resource use.

Epidemiology

COPD is the most common form of lung disease and the third leading cause of chronic morbidity and mortality in the United States and worldwide, which is primarily attributable to its link with smoking. The U.S. Centers for Disease Control and Prevention estimates that 18.1% of all adults in the United States smoke cigarettes and approximately 80% of COPD deaths are caused by smoking. In 2011, 12.7 million U.S. adults (aged 18 years and older) were estimated to have COPD. Statistics regarding COPD are shown in Box 28-1 . Restrictive pulmonary disease is most commonly caused by neuromuscular disorders, thoracic injuries, such as spinal cord injury (SCI), scoliosis, or obesity. Injury to the cervical and upper thoracic spinal cord disrupts the function of inspiratory and expiratory muscles, as reflected by the reduction in spirometry and lung volume variables. According to statistics available from the National Spinal Cord Injury Statistical Center, as of March 2014 there are an estimated 240,000 to 337,000 persons with SCI or spinal cord dysfunction in the United States. Of these patients, 79% are male, 14% have complete tetraplegia, and 45% have incomplete tetraplegia. Duchenne muscular dystrophy is one of the more common neuromuscular diseases that cause restrictive pulmonary dysfunction, with an incidence of 1 per 3500 male infants in the United States.

General Medical Management

Pharmacologic therapy for COPD includes inhaled quaternary anticholinergic and/or beta ₂ -adrenergic agonist bronchodilators, inhaled corticosteroids, and phosphodiesterase type-4 inhibitors. Oral theophylline can improve respiratory muscle endurance and provide ventilatory stimulation. Vaccination against influenza and pneumococcal pneumonia should be initiated. For those with emphysema resulting from alpha ₁ -antitrypsin deficiency, alpha ₁ -antitrypsin augmentation therapy can be efficacious. In addition, several treatments prolong life or reduce progression in this disease, and these include smoking cessation, noninvasive mechanical ventilation, LVRS, combined long-acting beta-agonists with inhaled corticosteroids, and oxygen therapy.

Oxygen Therapy

Long-term oxygen therapy, provided greater than 15 hours per day, improves survival and quality of life in COPD if hypoxemia is present with arterial oxygen saturation (Sa o ₂ ) less than 88% or arterial blood gas of less than 55 mm Hg. It can also improve exercise tolerance, sleep, and cognitive outcomes. Long-term oxygen therapy is also needed if the patient’s Sa o ₂ is less than 89% and there is evidence of pulmonary hypertension or peripheral edema, suggesting congestive cardiac failure, or polycythemia.

Oxygen concentrators have become the most popular method of providing oxygen in the home. Portable models are readily available and can be used with an AC or a DC inverter. Some models are as light as 6 lb, with the average weight ranging between 6 and 20 lb. Most models have batteries that can be recharged in as little as 2 hours and have battery running times as long as 6 hours. Portable concentrators can easily be carried on a pull cart or on the body with a shoulder strap or waist harness. Most units are able to deliver 1 to 6 L/min. Some companies have produced models that provide up to 8 L/min of oxygen and have two flow meters so that two individuals can use oxygen from the same concentrator if the total use is no more than 8 L/min. Other systems incorporate a refill station as part of the concentrator, so that portable oxygen cylinders can be filled over a couple of hours. An oxygen-conserving regulator allows the oxygen to last four times as long. An oxygen cylinder can now be safely mounted on a motorized wheelchair if the motors and batteries are sealed and both are covered by a rigid housing.

Chest Physical Therapy

A good understanding of pulmonary function tests ( Table 28-1 and Figure 28-1 ), as well as the mechanics and work of breathing in normal and diseased states, is essential in planning an effective pulmonary rehabilitation program. Breathing exercises begin with relaxation techniques, which then become the foundation for breathing retraining. Retraining techniques for persons with COPD include pursed lip breathing, head-down and bending-forward postures, slow deep breathing, and localized expansion exercises or segmental breathing. These techniques maintain positive airway pressure during exhalation and help reduce overinflation. Although diaphragmatic breathing is widely taught, it has been shown to increase the work of breathing and dyspnea compared with the natural pattern of breathing in the patient with COPD. The other component occasionally used to reduce fatigue is respiratory muscle endurance training, which usually concentrates on inspiratory resistance training. Training of the expiratory muscles, however, has also been found to be of some value.

Lung volumes in health and disease. The breathing pattern is read from right to left. The obstructive pattern demonstrates prolonged expiration. FRC, Functional residual capacity; RV, residual volume; TLC, total lung capacity; VC, vital capacity.

Airway clearance strategies are indicated for persons with (1) abnormal cough mechanics (e.g., muscle weakness), (2) altered mucus rheology (e.g., cystic fibrosis), (3) structural airway defects (e.g., bronchiectasis), and (4) altered mucociliary clearance (e.g., primary ciliary dyskinesia). Clearance of secretions is mandatory to reduce the work of breathing, improve gas exchange, and limit infection and atelectasis. For chest physical therapy to be effective, mucoactive medications must be given. These include expectorants, mucolytics, bronchodilators, surfactants, and mucoregulatory agents that reduce the volume of mucus secretion. Antitussives must be used for uncontrolled coughing, which can precipitate dynamic airway collapse, bronchospasm, or syncope.

Techniques for clearing secretions include postural drainage, manual or device-induced chest percussion and vibration, device-induced airway oscillation, incentive spirometry, and other devices and measures that improve the ability to cough. Head-down tilt positions for postural drainage should be used with caution in persons with severe heart disease. In a manually assisted cough, the patient’s abdomen is compressed while the patient controls the depth of inspiration and the timing of opening and closing the upper airway. Noninvasive intermittent positive-pressure ventilation (NIPPV) with air stacking or glossopharyngeal breathing (GPB) is used to increase the depth of inspiration when inspiratory muscles are too weak to produce a deep breath. Air stacking is holding a portion of two or more breaths to fully inflate the lungs before exhalation. In GPB, the person uses the tongue to breathe. The technique is described more fully later in this chapter. When an upper motor neuron lesion above the midthoracic level has paralyzed the abdominal muscles, functional electrical stimulation of these muscles can produce a cough.

Positive expiratory pressure mask therapy followed by “huff coughing” is a useful technique when other methods of mobilizing secretions are not tolerated. Autogenic drainage is a secretion clearance technique that combines variable tidal breathing at three distinct lung volume levels, controlled expiratory airflow, and huff coughing. The CoughAssist Mechanical In-Exsufflator cough machine ( Figure 28-2 ), manufactured by Philips HealthCare Respironics (Murrysville, Pa.), provides deep inspiration through a face mask or mouthpiece, or with an adapter, to the patient’s endotracheal or tracheostomy tube, followed rapidly by controlled suction. It has been shown to provide highly effective secretion removal. The device must be used with caution and is contraindicated in patients with bullous emphysema or a history of pneumothorax or pneumomediastinum in the recent past, especially if they are a result of barotrauma.

CoughAssist Mechanical In-Exsufflator cough machine with mother and child. The mother is using the machine at the child’s tracheostomy.

Exercise Conditioning: General Considerations

Aerobic exercise is the backbone of any pulmonary rehabilitation program. The inclusion criteria for exercise in pulmonary rehabilitation are straightforward. A candidate must demonstrate a decrease in functional exercise capacity as a result of pulmonary disease and be able to participate safely in a rigorous cardiorespiratory endurance training program. Cardiopulmonary exercise testing is necessary for the selection and evaluation of individuals in several circumstances before exercise conditioning. Indications for cardiopulmonary exercise testing have been adopted by the American Thoracic Society and the American College of Chest Physicians ( Box 28-2 ). The pulmonary disease should be relatively stable. Medical comorbidities that contraindicate exercise should be absent. Patients should not have orthopedic or cognitive disabilities that prevent exercise. Patients must be motivated to exercise on a consistent basis. Finally, patients should abstain from tobacco products.

Exercise Prescription for Pulmonary Rehabilitation

Exercise prescription guidelines are largely based on programs in which the majority of participants are patients with COPD. These guidelines, however, appear to be appropriate for patients who also have other pulmonary diseases. Exertional dyspnea is among the most frequently experienced symptoms of pulmonary diseases and leads to physical disability and functional impairment. Cardiorespiratory exercise training is often effective for decreasing exertional dyspnea. Provided the cardiovascular, respiratory, and neuromuscular systems have adequate reserve to undergo a program of progressive exercise, skeletal muscles can develop an increased ability to sustain physical activity. After training, muscle oxygenation might be improved, which lowers blood lactate levels at any given level of strenuous exercise. The confluence of increased oxygen extraction by the muscles and lower blood lactate lessens carbon dioxide production and the ventilatory requirement for a given workload.

The American Thoracic Society, the American College of Chest Physicians, and the American College of Sports Medicine have provided recommendations for pulmonary rehabilitation exercise. In general, pulmonary rehabilitation exercise programs should include cardiorespiratory endurance training of larger muscle groups. Overground or treadmill walking is generally the preferred method because walking is a functional activity. Leg cycling is an acceptable alternative. Arm cycling can also be incorporated. Many patients, however, might have difficulty tolerating arm cycling because of an increased ventilatory drive that could worsen the patient’s dyspnea during the activity. Resistance and flexibility exercises might also improve functional capacity in patients with pulmonary diseases. The most specific exercise prescription guidelines have been provided by the American College of Sports Medicine ( Table 28-2 ).

It is imperative that the personnel supervising the exercise program are appropriately trained in the implementation of exercise prescriptions in people with chronic illnesses and special needs. The American College of Sports Medicine offers certification programs to those with appropriate backgrounds, such as exercise science or kinesiology, nursing, occupational therapy, physical therapy, and respiratory therapy. In the initial exercise sessions, the individuals supervising the exercise program should monitor patients closely and adjust the intensity or duration of the session according to the appearance of exertional symptoms. After the patient is established at an appropriate intensity and duration, the progression of the patient must be monitored and evaluated to adjust the prescription for optimal effectiveness. The goal of the program should be a safe, effective, and enjoyable exercise regimen. Although beneficial results have been observed with exercise programs of 8 to 12 weeks in healthy individuals, those with pulmonary diseases might require longer periods of participation to show substantial results.

Exercise in Chronic Obstructive Pulmonary Disease

All studies of exercise in COPD take into account the severity of the respiratory disability ( Table 28-3 ). Numerous studies have been carried out on the effects of exercise on patients with COPD ( Box 28-3 ). * In patients with COPD, cardiorespiratory endurance exercise therapy has been shown to improve maximum or symptom-limited aerobic capacity, timed walk distance, and health-related quality of life. Adding resistance training to the rehabilitative regimen can provide additional benefits such as increased fat-free mass and muscle strength.

* References .

After an initial exercise rehabilitation program, patients must continue to participate in routine exercise to prevent the positive effects of exercise from being lost. Continuous outpatient exercise training, home-based or community-based exercise programs, or exercise training in groups of persons with COPD is necessary to sustain the benefits acquired during the initial rehabilitation program.

Exercise in Asthma

Asthma severity guidelines published in 1997 and updated in 2002 by the National Heart, Lung, and Blood Institute are based on clinical symptoms during the day and at night, and on the results of pulmonary function testing. The two major categories of patients with asthma are those who have it intermittently and those who have persistent asthma. Bronchial biopsies in patients with intermittent asthma show evidence of ongoing airway inflammation. Studies have shown that aerobic exercise improves overall fitness and health of patients with asthma.

A mouse model of asthma has been developed in which the effects of exercise have been studied. Exercise decreased the activation of the transcription factor nuclear factor-kappaB in the lungs of the mice. This factor regulates the expression of a variety of genes that encode inflammatory mediators. Moderate-intensity aerobic exercise training of the mice decreased leukocyte infiltration, cytokine production, adhesion molecule expression, and structural remodeling within the lungs. It is suggested that aerobic exercise in patients with asthma might reduce airway inflammation in a similar manner. By contrast, exercise itself can induce bronchoconstriction in some patients with asthma.

A study in patients with asthma found that airway vascular hyperpermeability, eosinophilic inflammation, and bronchial hyperactivity are independent factors predicting the severity of exercise-induced bronchoconstriction. Rundell et al. have described a laboratory method, eucapnic voluntary hyperpnea, that identifies 90% of athletes who have exercise-induced bronchoconstriction. The test is done by having athletes breathe 5% carbon dioxide and attempt to breathe for 6 minutes at a target ventilation equivalent to 30 times the baseline forced expiratory volume in 1 second (FEV ₁ ). If eucapnic voluntary hyperpnea is positive, there is a decrease in FEV ₁ of 10% to 19%.

Because exercising in cold air is known to increase bronchial responsiveness compared with exercising in warm air, a study was done to determine whether facial cooling plays a role in children with asthma. It was found that facial cooling, combined with either cold or warm air inhalation, caused greater exercise-induced bronchoconstriction than with cold air inhalation. This could indicate that vagal mechanisms play a role in exercise-induced asthma.

Barreiro et al. have studied the perception of dyspnea in patients with near-fatal asthma at both rest and the end point of various forms of exercise compared with other patients with asthma. Exercise tolerance was similarly reduced in both groups, but perception of dyspnea both at rest and at peak exercise was significantly lower in the group with near-fatal asthma.

Exercise in Cystic Fibrosis

An estimated 30,000 persons in the United States and 70,000 worldwide suffer from cystic fibrosis, which is an autosomal recessive disorder. The basic defect is one of chloride transport, which produces viscous mucus that inhibits the capability of the lungs to clear infection. The patient ultimately suffers from severe combined obstructive–restrictive pulmonary disease. The abnormal viscosity of the cystic fibrosis secretions is caused to a great extent by degenerating neutrophils that produce extracellular DNA. Dornase alfa (Pulmozyme), or recombinant human deoxyribonuclease, is an enzyme capable of digesting extracellular DNA. It is used daily by long-term nebulization for patients older than 5 years and whose forced vital capacity (FVC) is greater than 40%. Chest physical therapy of all pulmonary segments from one to four times daily is indicated, with increased frequency during exacerbations.

The Vest Airway Clearance System (Hill-Rom, St. Paul, Minn.) has become a popular method of providing the percussion and vibration necessary to loosen secretions. An air pulse generator rapidly inflates and deflates an inflatable vest, compressing and releasing the chest wall. This process is called high-frequency chest wall oscillation. It eliminates the need for intensive physical involvement by a caregiver. It also increases airflow velocities, which create repetitive coughlike shear forces and decrease the viscosity of secretions.

Children with cystic fibrosis have reduced anaerobic performance and do not participate in activities requiring short bouts of high-energy expenditure to the same extent as healthy children. Klijn et al. carried out a study of anaerobic training on children with cystic fibrosis older than 12 years. No child had an FEV ₁ less than 55% of the predicted level. Children were trained 2 days per week for 12 weeks, with sessions lasting 30 to 45 minutes. Each anaerobic activity lasted 20 to 30 seconds. Three months after the end of training, anaerobic performance and quality of life were significantly higher in the trained group. A measurable improvement in aerobic performance, however, was not sustained.

Children with cystic fibrosis are now surviving into adulthood, with the median survival in 2004 being approximately 32 years. For children born and diagnosed with cystic fibrosis in year 2010, the median survival is predicted to be 37 years of age. The cornerstones of treatment that have produced this increase in survival are airway clearance, nutritional support, and antibiotic therapy.

The lung function of adults with cystic fibrosis has been studied with FEV ₁ . Thirty-six percent were found to have normal or mild lung dysfunction (FEV ₁ , 70% predicted), 39% had moderate dysfunction (FEV ₁ , 40% to 69% predicted), and 25% had severe dysfunction (FEV ₁ , less than 40% predicted). One third of adults with cystic fibrosis have multiple-resistance gram-negative organisms. A 3-year study of regular aerobic exercise in adults with cystic fibrosis has found that it reduced the expected decline in pulmonary function throughout that period. Appropriate vigorous aerobic exercise enhances cardiovascular fitness, increases functional capacity, and improves quality of life. Patients with cystic fibrosis should rarely be exercised in close proximity to one another, however, because of the possibility of transmission of Burkholderia cepacia , a highly transmissible bacterium that frequently infects patients with cystic fibrosis.

Survival in cystic fibrosis is correlated with maximal oxygen uptake. Blau et al. have found that an intensive 4-week summer camp program for both children and young adults improved exercise tolerance and nutrition in patients with cystic fibrosis.

Exercise in Disorders of Chest Wall Function

Numerous causes of chest wall dysfunction exist with both mechanical and neuromuscular components. The chest wall can be viewed as encompassing the rib cage, spine, diaphragm, abdomen, shoulder girdles, and neck. Distortions of the trunk are also reflected in distortions of the heart, lungs, airway, and abdominal contents. Many conditions negatively affect the chest wall, including ankylosing spondylitis, pectus excavatum, obesity, the sequelae of thoracoplasty or phrenic nerve crush for the treatment of pulmonary tuberculosis, neuromuscular diseases with weakness of the respiratory bellows mechanism and superimposed spinal curvatures, and Parkinson disease. Ventilatory muscle training in these disorders can reduce respiratory muscle fatigue. Persons with Parkinson disease have shown overall improvement with pulmonary rehabilitation. Patients with developmental disorders are a heterogeneous group in which severe scoliosis is commonly seen. Exercise and other ongoing rehabilitation techniques, such as positioning, and management of spasticity and dysphagia, are of value in their treatment.

Exercise in Paradoxical Vocal Fold Dysfunction

Paradoxical vocal fold dysfunction is caused by the vocal folds coming together during inspiration, instead of opening normally. The diagnosis of paradoxical vocal fold dysfunction is based on patient history and laryngoscopy. The disorder can occur from adolescence to old age. In one study by Patel et al., 90% of the patients were female, 56% of them had asthma, 12% had laryngeal findings suggestive of gastroesophageal reflux disease, 12% had findings of chronic laryngitis, and 33% had additional findings of laryngomalacia, vocal fold motion impairment, sulcus vocalis, nodules, and subglottic stenosis. These additional findings were mostly seen in the exercise-induced group. If the patient is symptomatic during the examination, a flow-volume loop of the FVC shows a flattening of the inspiratory loop, indicative of the low flow associated with partial obstruction in this area during inspiration. Neurologically based dystonias are also a common cause. Throat tightness, dysphonia, and inspiratory difficulty can occur. Speech therapy can provide respiratory retraining. Acute exacerbations can be relieved by administration of helium-oxygen (70%:30%) with or without NIPPV. Direct vocal cord injection of botulinum toxin A is also used.

Nutritional Issues

In moderate to severe COPD, weight loss is common and is related to decreased exercise capacity and health status and increased morbidity and mortality. To determine the exact cause of weight loss it is important to look at the underlying mechanism of weight loss and specific tissue loss. Weight loss could be a result of high insulin resistance, high catecholamine levels, and dyslipidemia. More specifically, loss of fat mass is generally caused by energy imbalance, whereas fat-free mass loss could be a result of substrate and protein metabolism.

Creutzberg et al. studied nutritional treatment of the severely underweight patient in an inpatient program. Nutritional supplementation therapy with two or three 200-mL oral liquid nutritional supplements daily in these nutritionally depleted patients with COPD produced increases in body weight, fat-free mass, maximal inspiratory mouth pressure, handgrip strength, and peak workload. Symptoms and impact scores on the St. George’s Respiratory Questionnaire also improved. Maintenance oral glucocorticosteroid treatment blunted the response with regard to maximal inspiratory mouth pressure and peak workload, as well as the symptom score.

Later studies found that total daily energy expenditure in patients with COPD, whether they were underweight or not, has been shown to be no different than in healthy persons. Insufficient food intake was found to be the cause of the malnutrition. Patients had greater success gaining weight when their total energy intake was 1.3 times higher than their resting energy expenditure. It was also found that smaller doses (125 mL) of a dietary supplement led to greater improvements. The smaller doses caused less bloating and satiety, which was found to be less compromising to diaphragmatic movement, and patients were less likely to cut out meals.

The energy cost of the exercise associated with a pulmonary rehabilitation program was estimated to be 191 kcal/day. Protein supplements with a high proportion of carbohydrates over fat are necessary when vigorous exercise training results in negative energy balance and weight loss. In selected well-nourished patients, it might actually increase the shuttle walking performance.

Diet counseling and self-management with changes in dietary behavior should start early in the course, when the patient with COPD is still under the care of a primary physician. Practical suggestions for shopping, food preparation, and eating smaller, more frequent meals should be offered. When fatigue, dyspnea, swallowing, or poor appetite interferes with eating, a dietitian can be helpful. Involuntary weight loss is best addressed preventively.

Psychosocial Support

Biopsychosocial considerations for persons with pulmonary dysfunction include the ongoing education of the patient and family, vocational counseling, and disability evaluation. Occupational therapy can also provide patients with severe respiratory disease counseling on energy conservation and techniques for performing the basic activities of daily living. Depression and anxiety are very common comorbidities associated with COPD because of the often drastic limitations in functional activities and the panic associated with severe dyspnea. Antidepressant and anxiolytic medications are often useful adjuncts to counseling.

Table 28-4 presents a summary of recommendations, statements, and grades in the Evidence-Based Guidelines on Pulmonary Rehabilitation with Strength of Evidence/Balance of Benefits Grading System.

Mechanical Ventilation

Within the past 25 years, there has been a dramatic reduction in the use of body ventilators (iron lungs). Their main function is to simulate the function of the inspiratory muscles. The intermittent abdominal pressure ventilator simulates the function of the expiratory muscles. Intermittent positive-pressure ventilation (IPPV) via noninvasive nasal-mouth interfaces or via tracheostomy is now the method of choice because the equipment is lightweight and portable, and powered by either AC or DC current. No contact is made with the individual other than the nasal-mouth interface or the attachment to the tracheostomy tube ( Figures 28-3 to 28-6 ).

Respiratory assistive devices superimposed on a graphic representation of the vital capacity and tidal volume. Airway (−), Ventilation by negative pressure on airway, producing suctioning; airway (+), ventilation by positive pressure on airway, producing inspiration; body (−), ventilation by negative pressure on body, producing inspiration; body (+), ventilation by positive pressure on body, producing expiration. GPB, Glossopharyngeal breathing; IPPV, intermittent positive-pressure ventilation; NPBV, negative-pressure body ventilator; PAP, positive airway pressure; PPBV, positive-pressure body ventilator.

Nasal intermittent positive-pressure ventilation in a tetraplegic ventilator user with postpolio syndrome. The ventilator is a typical portable volume ventilator.

Mouth intermittent positive-pressure ventilation with angulated mouthpiece in a tetraplegic ventilator user with postpolio syndrome. The mouthpiece is held with teeth and lips.

Mouth intermittent positive-pressure ventilation (IPPV) with angulated mouthpiece and without lip seal in a ventilator user with postpolio syndrome. She is taking a nap in her wheelchair. She can hold the IPPV hose with her hands on her chest. She has some ability to breathe on her own and is a good frog breather when she is awake.

Portable ventilators are volume ventilators designed 25 years ago, high-span bilevel positive airway pressure units, and laptop volume ventilators ( Figure 28-7 ). For further information on the wide range of noninvasive ventilator choices, the reader is referred to a publication by Benditt.

Mouth intermittent positive-pressure ventilation (IPPV) in a laptop ventilator user with “upside-down polio” (upper trunk weaker than lower trunk and legs) and severe kyphoscoliosis. He is breathing continuously, with abdominal muscles when erect. The ventilator allows the muscles to rest. It is mounted in front of the scooter seat. He uses console volume ventilator and tracheostomy IPPV at night. Supine, he has no “free time” off the ventilator.

Air stacking (adding consecutive quantities of air into the lungs), maximal insufflations (passively inflating the patient’s lungs to maximal capacity), assisted coughing, and noninvasive ventilation are described as respiratory muscle aids by Bach. Bach has also developed an oximetry feedback respiratory aid protocol. In this protocol, the oximeter is used to provide patients and their families with feedback to maintain oxyhemoglobin saturation by pulse oximeter (Sp o ₂ ) greater than 94%, which is accomplished by maintaining effective alveolar ventilation and eliminating airway secretion. If the Sp o ₂ decreases to less than 95% in the patient with neuromuscular disease, it is attributable to one or more of three causes: (1) hypoventilation during which there will also be hypercapnia, (2) secretions, or (3) the development of intrinsic lung disease (usually gross atelectasis or pneumonia). Patients and families are taught to pursue airway clearance techniques conscientiously and to use NIPPV continuously. If these measures fail to bring the Sp o ₂ back to normal or to baseline levels, patients must be evaluated by their clinician or in the emergency room. They should be admitted if necessary. Family members or primary care providers need to remain with the patient in the hospital to perform the ongoing routine of secretion removal. The routine itself is typically too time-consuming for hospital personnel to be able to remove secretions with the frequency that is necessary during an acute respiratory infection. When there is inadequate social support, hospital personnel usually find it necessary to intubate the patient for secretion removal and ventilation.

Diaphragmatic pacing ( Figure 28-8 ) is an alternative method of ventilation that has been available for more than 35 years. The system attained a higher level of reliability and broader application in the early 1990s. Infection and component failure are now rare complications. The need for the patient to retain a tracheostomy because of obstructive sleep apnea remains common. Approximately 1500 phrenic nerve pacers have been implanted worldwide in persons of all ages. Many users have been successfully paced for more than 20 years. Diaphragmatic pacing is indicated in patients with congenital central hypoventilation syndrome (or Ondine curse), acquired central hypoventilation syndrome, and high SCI injury. Patients with inadequate social or financial support, poor motivation, or associated medical problems might not be good candidates. Although it is not common, the patient with a diaphragmatic pacer can require a mechanical ventilator as a backup during severe respiratory tract infections.

Bilateral diaphragmatic pacemaker use in a child with central hypoventilation syndrome.

The pacing system consists of an external transmitter and antenna, and implanted electrodes and receiver. The working life expectancy of the receiver is for the lifetime of the patient, and batteries last for 2 to 3 weeks. A bipolar electrode is available for use in persons who already have demand cardiac pacers. Advanced warning is given of transmitter battery failure, with a gradual decrease in tidal volume over several days. The cervical implant is recommended in the older child and adult, with “customized” stimulation variables that enable pacing with small numbers of residual fibers. Surgery in the supraclavicular region of the neck is relatively simple, and hospitalization is typical, although the procedure can be performed in an outpatient setting. Although thoracic phrenic nerve implants for infants and younger children have required thoracotomy in the past, thoracoscopic placement of the electrodes has now been reported in children as young as 5 years. Remote monitoring can be used to assess effectiveness and to diagnosis problems.

Krieger and Krieger reported performing 10 nerve transfers in six patients with SCI at the C3 to C5 level, with axonal loss in the phrenic nerves to the extent that pacing was not possible. In their technique, the fourth intercostal nerve was attached to the distal segment of the phrenic nerve 5 cm above the diaphragm. The pacemaker was implanted on the phrenic nerve distal to the anastomosis. The average interval from surgery to diaphragmatic response to electrical stimulation was 9 months. All patients were able to tolerate diaphragmatic pacing as an alternative to IPPV.

Intramuscular diaphragm electrodes implanted via laparoscopic surgery were reported to successfully stimulate the phrenic nerves in one ventilator-dependent patient with tetraplegia. In patients having only a single phrenic nerve that can be paced, combined intercostal muscle and unilateral phrenic nerve stimulation has also been shown to maintain ventilatory support.

Lung Volume Reduction Surgery

LVRS is used in patients with advanced emphysema. In LVRS, 20% to 30% of one or both lungs (usually at the apices) is removed. Decramer has reported the short-term results of six randomized studies, including the National Emphysema Treatment Trial. These studies have shown reduced hyperinflation (residual volume and total lung capacity decreased) and improved FEV ₁ and FVC. The 6-minute walk increased significantly and quality of life improved. In general, inspiratory muscle function (maximal inspiratory pressure and maximal transdiaphragmatic pressure) also improved. Combining LVRS with exercise produces greater benefits than exercise alone.

Not all patients will benefit from LVRS. Patients with an FEV ₁ less than 20% predicted and homogeneous disease, or a diffusion capacity less than 20% predicted, experience an increased mortality rate after LVRS. Additional studies suggest that patients getting the most benefit from LVRS are those with emphysema predominately in upper lobes who also have low postrehabilitation exercise capacity. Conversely, patients with non–upper lobe involvement and high postrehabilitation measures of maximal work received little benefit from LVRS. The results of the National Emphysema Treatment Trial suggest that all LVRS candidates should first enroll in a pulmonary rehabilitation program because some patients can improve to the point that they might not qualify for the surgery. Furthermore, participation in a pulmonary rehabilitation program before LVRS helps to both identify appropriate surgical candidates and helps to ensure that candidates have appropriate levels of compliance and an understanding of their condition.

Bronchoscopic LVRS is an alternative treatment option, which is a less invasive and potentially beneficial intervention for patients who may not be candidates for traditional LVRS. There are many different interventions, ranging from various stents, occluders, polymers, coils, and thermal vapor ablation. Stapling and plication of the most emphysematous tissue are carried out. Atelectasis can also be induced in these areas with the use of endobronchial sealants or valves. Extraanatomic tracts between the major airways and the emphysematous tissue are created and prevented from collapsing with stents to facilitate expiratory airflow.

Lung Transplant

Lung transplants are now performed worldwide. Living donor, lobar, and split-lung procedures are more common in children than in adults. Cystic fibrosis and primary pulmonary hypertension are the two main diseases of children for which lung transplant is performed. COPD is the main reason for lung transplant in adults, although pulmonary hypertension and pulmonary fibrosis are also common presenting diagnoses. Ongoing smoking is an absolute contraindication to lung transplant. Relative contraindications in most programs include previous cancer, psychiatric diagnosis, obesity, and correctable coronary artery disease. Fifty-eight percent of programs in North America that have been queried have a minimum requirement for exercise capacity to be considered for lung transplant. Covering a minimum of 600 feet on a 6-minute walk test is the most common requirement, although some programs require only 250 feet. If an individual can only transfer from bed to chair, 46% of lung transplant centers consider this an absolute contraindication to lung transplant, and 52% consider it a relative contraindication.

Obesity-Related Pulmonary Dysfunction

Data from the 2009 to 2010 National Health and Nutrition Examination Survey indicate an estimated 35.5% of adults in the United States were overweight or obese (body mass index [BMI] > 25). Seventeen percent of U.S. children and adolescents are estimated to be overweight. All racial and ethnic groups and both genders are affected. Primary respiratory complications associated with obesity include obstructive sleep apnea, obesity-hypoventilation syndrome, and asthma. Chronic hypoxemia related to obesity-hypoventilation syndrome can lead to polycythemia, pulmonary hypertension, cardiac dysrhythmias, and right ventricular failure. One study reported that three of four adults who presented to the emergency department with acute asthma were either overweight (BMI = 25 to 29.9; 30%) or obese (BMI > 30; 44%). Other conditions that can be associated with obesity include atelectasis, pneumonia, venous thrombosis, and pulmonary embolism. Daily physical activity is important in preventing and treating overweight and obesity because many of the aforementioned conditions are improved with weight loss.

Obesity increases the metabolic requirements of breathing and physical activity, resulting in decreased exercise tolerance. The weight relative maximal volume of oxygen consumption (V o _2 max ) in obese persons can be significantly decreased compared with controls. Norman et al. studied severely obese adolescents (BMI > 40) and found that although absolute V o _2max (mL O ₂ /min) was similar to controls, walk/run distance was approximately 60% of the control average. Although obese adults with COPD might have greater fatigue, functional impairment, and significantly lower 6-minute walk distance compared with normal-weight individuals with COPD, similar relative improvements in walk distance are seen after pulmonary rehabilitation.

Spinal Cord Injury and Pulmonary Dysfunction

In SCI, there is diminished cardiopulmonary and circulatory function, as well as lower limb muscle atrophy and bone mass reduction. Patients with high cervical cord injuries, including children as young as 3 years, can learn neck breathing or GPB as forms of voluntary respiration. This allows some time off the ventilator. In GPB (or frog breathing), air is pumped into the lungs by the patient using the tongue as a piston ( Figure 28-9 ). This technique is known as glottic press to speech pathologists. They teach it to patients who have had a laryngectomy, to pump air into the esophagus for esophageal speech. GPB can be used for a number of purposes in addition to being an alternative form of breathing. GPB can improve vocal volume and flow of speech to allow the patient to call for help, and to provide the deep breath needed for an assisted cough.

Glossopharyngeal breathing (GPB) tracing and results compared with pulmonary function tests without GPB in a tetraplegic ventilator user with postpolio syndrome. ERV, Expiratory reserve volume; f, frequency; gulp, volume or single GPB stroke; VE, minute ventilation; Vt, tidal volume.

Physiatric Interventions in Enhancing Outcomes

The goal of transplant rehabilitation is to improve functional outcomes and facilitate reintegration into a fulfilling life and lifestyle using a comprehensive, interdisciplinary, structured, and integrated approach between the physiatrist and primary transplant team. Long-term success of organ transplantation is largely dependent on a high-quality aftercare program that integrates essential medical management with a customized rehabilitation regimen.

For all solid organ transplantation patients, a preoperative functional, psychosocial, and medical baseline must be established including a comprehensive medical history and characterization of all functional deficits associated with the patient’s end-stage organ disease. This is vital to formulating an individualized comprehensive therapeutic plan of exercise and mobilization. The physiatrist must perform a detailed musculoskeletal, neurologic, and functional assessment with emphasis placed on the specific body systems adversely affected by immobilization.

During the early postoperative phase, vigilant medical surveillance and monitoring must be employed to treat transplant-associated medical complications, ensure adequate immunosuppression, minimize the risk of donor organ rejection, prevent opportunistic infections, and maintain rehabilitation goals with the implementation of measures aimed at the prevention of contractures, deep vein thrombosis and pulmonary embolism, skin breakdown, and bowel or bladder dysfunction. The rehabilitation team must also be cognizant of the clinical features of acute and chronic rejection in all types of transplantation surgeries as well as other medical complications.

Hypertension

Corticosteroids and calcineurin inhibitors can have pressor effects, resulting in elevated blood pressure. In addition to the cardiovascular risk, arterial hypertension can have a significant long-term effect on morbidity and mortality in transplant patients and is one of the long-term prognostic factors for survival. This is particularly problematic in renal transplant patients in whom blood pressure is frequently found to be elevated postoperatively. Arterial hypertension is prevalent in renal transplant recipients and is associated with reduced allograft and patient survival. In a single-center study, only 5% of kidney transplant patients were normotensive, as defined by blood pressure less than 130/80 mm Hg. Immunosuppressive agents can cause hypertension by various mechanisms, including catechol-induced and endothelin-induced vasoconstriction, diminished nitric oxide-induced vasodilatation, and sodium retention. Additional causes of posttransplant hypertension include sequelae of antibody-mediated rejection and renal artery stenosis. Calcium channel blockers may be the most useful medication for treatment of calcineurin inhibitor-induced vasoconstriction. The cardioprotective and nephroprotective effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are also usually preferred in transplant patients.

Hyperlipidemia

Nearly all immunosuppressive agents can lead to hyperlipidemia that is often refractory to dietary management alone. Pravastatin (Pravachol) and fluvastatin (Lescol, Canef, Vastin) are the most thoroughly studied agents in combination with immunosuppressive agents. Patients receiving treatment with statins and calcineurin inhibitors should undergo creatine kinase level monitoring because the combination may adversely lead to rhabdomyolysis.

Steroid-Induced Hyperglycemia and Posttransplant Diabetes

Immunosuppression with steroids or calcineurin inhibitors has been associated with an increased incidence of insulin-dependent posttransplant diabetes. If posttransplant hyperglycemia is detected, it is essential to intervene medically either with dietary measures, oral glycemic medications, and/or insulin.

Renal Insufficiency

Given the nephrotoxicity associated with immunosuppressants, particularly calcineurin inhibitors, renal function variables should be monitored routinely, to include serum creatinine, urea values, and glomerular filtration rate. Ensuring adequate daily fluid intake and avoiding additional nephrotoxic agents, such as nonsteroidal antiinflammatory drugs, are simple measures employed to avoid renal compromise. If the posttransplant patient exhibits renal insufficiency, changes to the immunosuppression regimen may be considered by the transplant team.

Infections

Posttransplantation infections pose a significant challenge in an immunosuppressed patient. The etiologic differential of the source of infection in these patients includes nosocomial, community-acquired, or donor organ–derived and may include opportunistic pathogens that become clinically significant in the immunosuppressed. The treatment team must have a very low threshold for initiating diagnostic testing, because posttransplant patients can initially present with subclinical signs and symptoms caused by an impaired inflammatory response and leukopenia. Graft rejection or graft-versus-host disease can also be confused with infection. The risk for certain types of infection and inciting organisms depends on the intensity and duration of the immunosuppression. A prophylactic antibiotic, antiviral, and antifungal may be prescribed, including cotrimoxazole for Pneumocystis carinii , valganciclovir for cytomegalovirus (CMV) IgG-positive organ donors and nonimmunized patients and amphotericin B to prevent candidiasis. Pathogens to consider within the first month posttransplantation include methicillin-resistant Staphylococcus aureus , vancomycin-resistant Enterococcus , Clostridium difficile colitis, as well as pulmonary infections (aspiration pneumonia, ventilator-associated or postsurgical), line-associated or catheter-associated infections, or infections of devitalized tissues and fluid collections. Other pathogens to consider in the first 6 months after transplantation are Mycobacterium tuberculosis , Nocardia , Leishmania , Epstein-Barr virus, herpes simplex virus, human herpes virus 6, hepatitis B virus, hepatitis C virus, and BK virus. Opportunistic infections can include Aspergillus and Listeria monocytogenes . Given the diversity of these organisms and complexity of drug interactions with many of the transplant-related medications, any antimicrobial management should be under the direction of the medical-surgical transplant team.

Immunosuppression

The physiatrist must be aware of the potential adverse effects associated with the numerous immunosuppressant medications administered following transplantation. A summary of the side effects of some of the most frequently used agents is provided in Table 28-5 . See Table 28-6 for the monitoring variables for a few immunosuppressive medications.

Table 28-5

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

Quality and Outcome Measures for Medical Rehabilitation The Geriatric Patient Burns Rheumatologic Rehabilitation Myelomeningocele and Other Spinal Dysraphisms Chronic Pain

Stay updated, free articles. Join our Telegram channel

Join